Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By giving a comprehensive assessment of the aggressiveness of the prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Thus, the over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.
- Bli medlem
- Om SwedenBIO